St. Jude Medical Receives CE Mark Approval for World’s Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson’s Disease

GraphicGraphic

Back to: News Release
Illustration of a male patient with the Brio(TM) deep brain stimulation system for treating the symptoms of Parkinson's disease. The device is usually implanted near the collarbone and sends mild electrical pulses to specific targets in the brain. The Brio deep brain stimulator is the world's smallest rechargeable neurostimulator approved to treat the symptoms of Parkinson's disease. The Brio deep brain stimulation system is not approved for use in the U.S. (Graphic: St. Jude Medical, Inc.)
Illustration of a male patient with the Brio(TM) deep brain stimulation system for treating the symptoms of Parkinson's disease. The device is usually implanted near the collarbone and sends mild electrical pulses to specific targets in the brain. The Brio deep brain stimulator is the world's smallest rechargeable neurostimulator approved to treat the symptoms of Parkinson's disease. The Brio deep brain stimulation system is not approved for use in the U.S. (Graphic: St. Jude Medical, Inc.)

Download Formats

Smart Multimedia Gallery

Illustration of a male patient with the Brio(TM) deep brain stimulation system for treating the symptoms of Parkinson's disease. The device is usually implanted near the collarbone and sends mild electrical pulses to specific targets in the brain. The Brio deep brain stimulator is the world's smallest rechargeable neurostimulator approved to treat the symptoms of Parkinson's disease. The Brio deep brain stimulation system is not approved for use in the U.S. (Graphic: St. Jude Medical, Inc.)
Illustration of a male patient with the Brio(TM) deep brain stimulation system for treating the symptoms of Parkinson's disease. The device is usually implanted near the collarbone and sends mild electrical pulses to specific targets in the brain. The Brio deep brain stimulator is the world's smallest rechargeable neurostimulator approved to treat the symptoms of Parkinson's disease. The Brio deep brain stimulation system is not approved for use in the U.S. (Graphic: St. Jude Medical, Inc.)Graphic

Illustration of a male patient with the Brio(TM) deep brain stimulation system for treating the symptoms of Parkinson's disease. The device is usually implanted near the collarbone and sends mild electrical pulses to specific targets in the brain. The Brio deep brain stimulator is the world's smallest rechargeable neurostimulator approved to treat the symptoms of Parkinson's disease. The Brio deep brain stimulation system is not approved for use in the U.S. (Graphic: St. Jude Medical, Inc.)

The Brio(TM) deep brain stimulator is the world's smallest rechargeable neurostimulator approved to treat the symptoms of Parkinson's disease. Slightly larger than the typical man's watch, the device is usually implanted near the collarbone and sends mild electrical pulses to specific targets in the brain. The Brio deep brain stimulation system is not approved for use in the U.S. (Photo: St. Jude Medical, Inc.)

The Brio(TM) deep brain stimulator is the world's smallest rechargeable neurostimulator approved to treat the symptoms of Parkinson's disease. Slightly larger than the typical man's watch, the device is usually implanted near the collarbone and sends mild electrical pulses to specific targets in the brain. The Brio deep brain stimulation system is not approved for use in the U.S. (Photo: St. Jude Medical, Inc.)

Download Formats

http://www.businesswire.com/multimedia/home/20090909005095/en/1847710/St.-Jude-Medical-Receives-CE-Mark-Approval

Download Formats